CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-28 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −139,751 | $95.80 | $13.4M | 9,493 |
| 2021-07-27 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +32,788 | $95.80 | $3.1M | 317,215 |
| 2021-07-27 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −32,788 | $140.01 | $4.6M | 284,427 |
| 2021-07-27 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −32,788 | $95.80 | $3.1M | 149,244 |
| 2021-07-27 | WILENSKY GAIL R Director | Exercise or conversion | +6,111 | $57.57 | $352K | 23,956 |
| 2021-07-27 | WILENSKY GAIL R Director | Sale | −6,111 | $139.32 | $851K | 17,845 |
| 2021-07-27 | WILENSKY GAIL R Director | Exercise or conversion | +6,111 | $61.23 | $374K | 23,956 |
| 2021-07-27 | WILENSKY GAIL R Director | Sale | −6,111 | $139.27 | $851K | 17,845 |
| 2021-07-27 | WILENSKY GAIL R Director | Exercise or conversion · Stock Options (Right to Buy) | −6,111 | $57.57 | $352K | 0 |
| 2021-07-27 | WILENSKY GAIL R Director | Exercise or conversion · Stock Options (Right to Buy) | −6,111 | $61.23 | $374K | 0 |
| 2021-07-26 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +5,813 | $95.80 | $557K | 290,240 |
| 2021-07-26 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −5,813 | $140.03 | $814K | 284,427 |
| 2021-07-26 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −5,813 | $95.80 | $557K | 182,032 |
| 2021-07-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +313 | $132.52 | $41K | 10,999.95 |
| 2021-05-25 | PFEIFFER GARY M Director | Grant or award | +1,363 | 23,265 | ||
| 2021-05-25 | RING TIMOTHY M Director | Grant or award | +1,363 | 22,234 | ||
| 2021-05-25 | WILENSKY GAIL R Director | Grant or award | +1,363 | 17,845 | ||
| 2021-05-25 | Lassiter Wright III Director | Grant or award | +1,363 | 3,281 | ||
| 2021-05-25 | MAIN TIMOTHY L Director | Grant or award | +1,363 | 20,951 | ||
| 2021-05-25 | Torley Helen Director | Grant or award | +1,363 | 6,260 |
Page 35 of 42 · 826 trades